Terconazole - Latest Advances

A Novel Highly Sensitive Derivatization-Free Spectrofluorimetric Approach for Analysis of the Antifungal Terconazole in Dosage Forms, Biological Fluids, and Environmental Water Samples: Assessment of Greenness and Blueness Profiles.

Journal: Luminescence : the journal of biological and chemical luminescence

Published: July 09, 2025

The future of non-invasive azole antifungal treatment options for the management of vulvovaginal candidiasis.

Journal: Expert review of anti-infective therapy

Published: June 04, 2025

Terconazole loaded edge-activated hybrid elastosome for revamped corneal permeation in ocular mycosis: In-vitro characterization, statistical optimization, microbiological assessment, and in-vivo evaluation.

Journal: International journal of pharmaceutics: X

Published: March 09, 2025

Exploring the potential of antifungal-loaded proniosomes to consolidate corneal permeation in fungal keratitis: A comprehensive investigation from laboratory characterization to microbiological evaluation.

Journal: International journal of pharmaceutics: X

Published: January 04, 2025

Optimizing Transdermal Drug Delivery with Novasome Nanocarriers: A Quality by Design (QbD) Framework.

Journal: Current drug delivery

Published: November 18, 2024

Survey of community pharmacists' opinions on drug scheduling in Ontario and Québec.

Journal: Journal of pharmaceutical policy and practice

Published: August 14, 2024

Amoebicidal Effect of COVID Box Molecules against Acanthamoeba: A Study of Cell Death.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 17, 2024

Exploring therapeutic approaches against Naegleria fowleri infections through the COVID box.

Journal: International journal for parasitology. Drugs and drug resistance

Published: February 26, 2024

Anti-COVID Drugs (MMV COVID Box) as Leishmanicidal Agents: Unveiling New Therapeutic Horizons.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: January 23, 2024

Terconazole, an Azole Antifungal Drug, Increases Cytotoxicity in Antimitotic Drug-Treated Resistant Cancer Cells with Substrate-Specific P-gp Inhibitory Activity.

Journal: International journal of molecular sciences

Published: September 29, 2022

PLGA-modified Syloid®-based microparticles for the ocular delivery of terconazole: in-vitro and in-vivo investigations.

Journal: Drug delivery

Published: July 15, 2022

Development of the stability-indicating method, structural elucidation of new photodegradation products from terconazole by LC-MS TOF, and in vitro toxicity.

Journal: Journal of pharmaceutical and biomedical analysis

Published: February 01, 2022

Filters

A Novel Highly Sensitive Derivatization-Free Spectrofluorimetric Approach for Analysis of the Antifungal Terconazole in Dosage Forms, Biological Fluids, and Environmental Water Samples: Assessment of Greenness and Blueness Profiles.

A Novel Highly Sensitive Derivatization-Free Spectrofluorimetric Approach for Analysis of the Antifungal Terconazole in Dosage Forms, Biological Fluids, and Environmental Water Samples: Assessment of Greenness and Blueness Profiles.

The future of non-invasive azole antifungal treatment options for the management of vulvovaginal candidiasis.

The future of non-invasive azole antifungal treatment options for the management of vulvovaginal candidiasis.

Terconazole loaded edge-activated hybrid elastosome for revamped corneal permeation in ocular mycosis: In-vitro characterization, statistical optimization, microbiological assessment, and in-vivo evaluation.

Terconazole loaded edge-activated hybrid elastosome for revamped corneal permeation in ocular mycosis: In-vitro characterization, statistical optimization, microbiological assessment, and in-vivo evaluation.

Exploring the potential of antifungal-loaded proniosomes to consolidate corneal permeation in fungal keratitis: A comprehensive investigation from laboratory characterization to microbiological evaluation.

Exploring the potential of antifungal-loaded proniosomes to consolidate corneal permeation in fungal keratitis: A comprehensive investigation from laboratory characterization to microbiological evaluation.

Optimizing Transdermal Drug Delivery with Novasome Nanocarriers: A Quality by Design (QbD) Framework.

Optimizing Transdermal Drug Delivery with Novasome Nanocarriers: A Quality by Design (QbD) Framework.

Survey of community pharmacists' opinions on drug scheduling in Ontario and Québec.

Survey of community pharmacists' opinions on drug scheduling in Ontario and Québec.

Amoebicidal Effect of COVID Box Molecules against Acanthamoeba: A Study of Cell Death.

Amoebicidal Effect of COVID Box Molecules against Acanthamoeba: A Study of Cell Death.

Exploring therapeutic approaches against Naegleria fowleri infections through the COVID box.

Exploring therapeutic approaches against Naegleria fowleri infections through the COVID box.

Anti-COVID Drugs (MMV COVID Box) as Leishmanicidal Agents: Unveiling New Therapeutic Horizons.

Anti-COVID Drugs (MMV COVID Box) as Leishmanicidal Agents: Unveiling New Therapeutic Horizons.

Terconazole, an Azole Antifungal Drug, Increases Cytotoxicity in Antimitotic Drug-Treated Resistant Cancer Cells with Substrate-Specific P-gp Inhibitory Activity.

Terconazole, an Azole Antifungal Drug, Increases Cytotoxicity in Antimitotic Drug-Treated Resistant Cancer Cells with Substrate-Specific P-gp Inhibitory Activity.

PLGA-modified Syloid®-based microparticles for the ocular delivery of terconazole: in-vitro and in-vivo investigations.

PLGA-modified Syloid®-based microparticles for the ocular delivery of terconazole: in-vitro and in-vivo investigations.

Development of the stability-indicating method, structural elucidation of new photodegradation products from terconazole by LC-MS TOF, and in vitro toxicity.

Development of the stability-indicating method, structural elucidation of new photodegradation products from terconazole by LC-MS TOF, and in vitro toxicity.